Previous 10 | Next 10 |
home / stock / zldpf / zldpf news
Zealand Pharma A/S (ZLDPF) Q1 2018 Results Earnings Conference Call May 16, 2018, 10:00 am ET Executives Britt Meelby Jensen - President and Chief Executive Officer Mats Blom - Executive Vice President and Chief Financial Officer Adam Steensberg - Executive Vice President, Chief ...
Zealand Pharma ( OTCPK:ZLDPF ): Q1 EPS of -DKK2.98 More news on: Zealand Pharma A/S, Earnings news and commentary, Read more ...
Company announcement - No. 14 / 2018 Zealand Pharma - Interim report for the first quarter of 2018 Copenhagen, May 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), the Copenhagen-based company focused on discovery, design and development o...
Press Release - No. 12 / 2018 Zealand hosts conference call on May 16 at 4 pm CET/10 am EDT to present first quarter results 2018 Copenhagen, May 14, 2017 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) announces that it will be hosting a conference call on ...
Press release - No 11 / 2018 Zealand Pharma to attend Deutsche Bank Securities 43rd Annual Health Care Conference, in Boston on May 8, 2018 Copenhagen, 2 May, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be presenting at ...
Company announcement - No. 13/2018 Zealand announces net sales of Soliqua ® 100/33 and Lyxumia ® /Adlyxin ® for the first quarter of 2018 Net sales of Soliqua ® 100/33 and Lyxumia ® /Adlyxin ® of EUR 14.5 million/USD 17.9 million in Q1 2018 ...
Company announcement - No. 12/2018 Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome Glepaglutide is in development as a new treatment option for patients with short bowel syndrome The pivotal phase 3 trial is on track for ...
Company announcement - No. 11 / 2018 Zealand's Annual General Meeting in 2018 Copenhagen, April 19, 2018 - Today, Zealand Pharma A/S (Zealand) (CVR-no. 20 04 50 78) held its Annual General Meeting in 2018 at the offices of Plesner Advokatpartnerselskab, Amerika Plads 37, 2100 Cope...
Press release - No. 10 / 2018 Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam Copenhagen, April 12, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will attend the Kempen Life Science ...
Press release - No. 9/2018 Zealand and Roche Diabetes Care enter Phase 3 study collaboration for treatment of congenital hyperinsulinism with dasiglucagon Zealand has entered a collaboration agreement with Roche Diabetes Care to use its Accu-Chek ® Combo ...
News, Short Squeeze, Breakout and More Instantly...
Zealand Pharma A/S Ord Company Name:
ZLDPF Stock Symbol:
OTCMKTS Market:
Zealand Pharma A/S Ord Website:
Company announcement – No. 35 / 2024 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE U...
Company announcement – No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO T...
Company announcement – No. 33 / 2024 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CAN...